Omicron boosters are a key milestone, but aren’t likely to woo new investors to Pfizer, Moderna
It’s a new milestone in the Covid-19 pandemic. People will soon roll up their sleeves and get jabbed with a booster shot tailored to the dominant coronavirus strain circulating in…